Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Ost, Piet; Reynders, Dries; Decaestecker, Karel; Fonteyne, Valérie; Lumen, Nicolaas; De Bruycker, Aurélie; Lambert, Bieke; Delrue, Louke; Bultijnck, Renée; Claeys, Tom; Goetghebeur, Els; Villeirs, Geert; De Man, Kathia; Ameye, Filip; Billiet, Ignace; Joniau, Steven; Vanhaverbeke, Friedl; De Meerleer, Gert

doi:10.1200/jco.2017.75.4853

Public

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Published in Journal of Clinical Oncology • Dec 14, 2017

Authors:

Piet Ost

Dries Reynders

Karel Decaestecker

Abstract

Purpose Retrospective studies suggest that metastasis-directed therapy (MDT) for oligorecurrent prostate cancer (PCa) improves progression-free survival. We aimed to assess the benefit of MDT in a randomized phase II trial. Patients and Methods In this multicenter, randomized, phase II study, patien...

Subject

Medicine

Interquartile range

Prostate cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!